Progressive fibrosing interstitial lung diseases (ILDs) encompass a wide range of diseases, including hypersensitivity pneumonitis, occupational diseases, granulomatous diseases, drug-induced diseases ...
Neil B. Minkoff, MD: Dr Oldham, as we start to think about treatment and the different treatment paradigms, what’s available clinically and available for patients? My understanding is there aren’t ...
More clinical guidance is needed for monitoring interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA), according to a new commentary. Though ILD is a leading cause of death among ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Monitoring of rheumatoid arthritis-associated interstitial lung disease remains highly variable and ...
Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function. 1, 2 Affecting up to 100,000 people in the U.S. and up to 5.6 ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider Jeffrey J. Swigris, ...
After a year of treatment, patients assigned to pirfenidone lost an average 66 mL of forced vital capacity (FVC) compared with a mean 146-mL decline in the placebo group, according to Ivan Rosas, MD, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...
Figure 1. Male, 46 years old, with IIP for 1 month, manifests FDG and FAPI imaging positive. (A, E, the MIP of FDG and FAPI imaging; B-C, axial FDG PET/CT, CT, and the FAPI PET/CT; The SUVmax of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback